KRYS
Krystal Biotech, Inc. Common Stock
$312.50
-3.14%
-9.93
Notify me if price changes either direction
Buy KRYS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
9.0B
Enterprise value
8.5B
Trailing PE
42.286095
Forward PE
31.377783
PEG Ratio
0.78260832537313
Enterprise to EBITDA
47.156
Enterprise to revenue
20.393
Price to book MRQ
7.5711513
Price to sales TTM
22.344494
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
417.3M
EBITDA
185.3M
Diluted EPS TTM
7.48
Total Cash (MRQ)
823.4M
Current ratio (MRQ)
9.459
Operating Cash Flow (TTM)
250.3M
KRYS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
May 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
